Cyril Allouche
2018
In 2018, Cyril Allouche earned a total compensation of $799.2K as Former Head of Finance and Corporate Controller, Principal Accounting Officer at Revance Therapeutics.
Compensation breakdown
| Bonus | $110,000 |
|---|---|
| Non-Equity Incentive Plan | $92,450 |
| Option Awards | $263,316 |
| Salary | $248,272 |
| Stock Awards | $75,188 |
| Other | $10,021 |
| Total | $799,247 |
Allouche received $263.3K in option awards, accounting for 33% of the total pay in 2018.
Allouche also received $110K in bonus, $92.5K in non-equity incentive plan, $248.3K in salary, $75.2K in stock awards and $10K in other compensation.
Rankings
In 2018, Cyril Allouche's compensation ranked 10,205th out of 14,244 executives tracked by ExecPay. In other words, Allouche earned more than 28.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,205 out of 14,244 | 28th |
Division Manufacturing | 4,114 out of 5,759 | 29th |
Major group Chemicals And Allied Products | 1,544 out of 2,122 | 27th |
Industry group Drugs | 1,305 out of 1,811 | 28th |
Industry Pharmaceutical Preparations | 1,004 out of 1,385 | 28th |
Source: SEC filing on March 25, 2019.
Allouche's colleagues
We found six more compensation records of executives who worked with Cyril Allouche at Revance Therapeutics in 2018.
2018
L Browne
Revance Therapeutics
Chief Executive Officer
2018
Caryn McDowell
Revance Therapeutics
General Counsel
2018
Abhay Joshi
Revance Therapeutics
Chief Operating Officer
2018
Tobin Schilke
Revance Therapeutics
Chief Financial Officer
2018
Todd Zavodnick
Revance Therapeutics
Former Chief Commercial Officer and President, Aesthetics & Therapeutics
2018
Lauren Silvernail
Revance Therapeutics